The FDA expanded the approval of the direct-acting antiviral (DAA) glecaprevir/pibrentasvir (Mavyret), making it the first ...

A new report from the Centers for Disease Control and Prevention shows Oregon has some of the worst hepatitis C rates in the ...

As national data show Oregon's hepatitis C rates are among the worst in the nation, state officials are emphasizing a need for increased community-based screenings and prevention and treatment se ...

The country has recorded a surge of hepatitis cases, and the alarming situation has called for better clarity in ...

The AIDS Project of Southern Vermont (APSVT) will participate in the nation’s largest coordinated National HIV Testing Day event by offering FREE rapid HIV and hepatitis C testing ...

A Supreme Court decision that could overturn the Affordable Care Act’s coverage mandate for preventive health screenings ...

New data from the Centers for Disease Control and Prevention shows Oregon is third worst in the nation for deaths from hepatitis C. While there is no vaccine available, it is treatable with proper ...

The debate over harm reduction continues to stir controversy in Portland as advocates push for a bill that would require ...

Mavyret marks the first and only direct-acting antiviral approved to treat both acute and chronic hepatitis C virus ...

FDA approves AbbVie's Mavyret for acute hepatitis C, expanding its use to patients 3 and older with or without cirrhosis ...

AbbVie Inc. (NYSE:ABBV) is one of the 12 best healthcare stocks to buy now. On June 12, the US Food and Drug Administration ...

Learn about 5 liver infections that can hide in your body for decades without symptoms. Discover warning signs and prevention ...